Aprea Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2017 to 2020

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Aprea Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2020.
  • Aprea Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $128K, a 52.3% decline year-over-year.
  • Aprea Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $4.98M, a 270% increase from 2019.
  • Aprea Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2019 was $1.35M, a 308% increase from 2018.
  • Aprea Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2018 was $330K, a 16.6% decline from 2017.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2020 $4.98M +$3.64M +270% Jan 1, 2020 Dec 31, 2020 10-K 2021-03-16
2019 $1.35M +$1.02M +308% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
2018 $330K -$65.6K -16.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-16
2017 $395K Jan 1, 2017 Dec 31, 2017 10-K 2020-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.